Skip to main content
Have a personal or library account? Click to login
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus Cover

The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

Endocrine Regulations
Volume 54 (2020): Issue 2 (April 2020)
By:  and    
Open Access
|May 2020
Authors

Authors

Douglas Edward Barre

ed_barre@cbu.ca

Department of Health Sciences, Cape Breton University, Sydney, Canada

Kazimiera Amelia Mizier-Barre

Department of Health Sciences, Cape Breton University, Sydney, Canada
DOI: https://doi.org/10.2478/enr-2020-0017 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 137 - 155
Published on: May 8, 2020
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
cinnamic acids and related compounds,
type 2 diabetes mellitus,
central obesity,
hyperglycemia,
hypertension,
dyslipidemia,
pro-thrombosis,
oxidation and inflammation
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2020 Douglas Edward Barre, Kazimiera Amelia Mizier-Barre, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 54 (2020): Issue 2 (April 2020)
Previous article